Concepedia

Maureen Illand

MI

Statistics

Publications

4

Citations

702

H-Index

4

Active since

1999

Affiliations

Cancer Research UK(Current)

Cancer Research UK Scotland Institute

University of Glasgow

Maureen Illand is an author at Cancer Research UK specializing in molecular oncology, molecular genetics, and cancer genetics.

Publications per year

1999–2001

4

Publications

4

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

Gordon Strathdee, Melanie Mackean, Maureen Illand et al. · Oncogene · 1999 · 352 citations

Life Sciences, Genetics, Molecular Genetics +17

Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes

Gordon Strathdee, Kim Appleton, Maureen Illand et al. · American Journal Of Pathology · 2001 · 203 citations

Medicine, Molecular Genetics, Oncology +10

Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes

Stephen T. Durant, Melanie M. Morris, Maureen Illand et al. · Current Biology · 1999 · 99 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.

Nicole J. Moreland, Maureen Illand, Y T Kim et al. · PubMed · 1999 · 48 citations

Medicine, Molecular Biology, Oncology +17

1–4 of 4